Home > News > Breast Cancer Drug Offers Better Responses
May 6th, 2005
Breast Cancer Drug Offers Better Responses
Abstract:
One of the latest, most promising treatments for some women with metastatic breast cancer is a new drug that increases the response rate of tumors and causes fewer side effects, researchers say.
The technology behind the drug, nanoparticle albumin-bound paclitaxel (nab-paclitaxel or AbraxaneTM) marks a breakthrough, say Vicente Valero M.D., and Edgardo Rivera, M.D., both in the Department of Breast Medical Oncology at M. D. Anderson.
Source:
cancerwise.org
Bookmark:
| Related Links |
American Pharmaceutical Partners
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||